Bank of America Global Materials Conference Agustin Izquierdo Chief Financial Officer February 26th, 2026 Cautionary statement The statements in this presentation relating to matters that are not historical facts are forward-looking statements. These forward-looking statements are based upon assumptions of management of LyondellBasell which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. When used in this presentation, the words "believe," "could," "int ...

Solid Execution and Momentum Entering 2026Annual sales of $3.5 billion, in line with guidanceOperating income of $516 million, including insurance settlement gain of $28 millionEBITDA(1) of $661 million, or 18.9% margin(1), including 0.8% increase from insurance settlement Strong operating cash flow of $557 million2023-2025 financial objectives met or exceeded and guidance set for 2026-2028Investment in a U.S. greenfield steel lattice facility to capitalize on the accelerating infrastructure spending trend ...

For the quarter ended December 2025, Williams Companies, Inc. (The) (WMB) reported revenue of $3.2 billion, up 16.6% over the same period last year. EPS came in at $0.55, compared to $0.47 in the year-ago quarter.The reported revenue represents a surprise of +1.8% over the Zacks Consensus Estimate of $3.14 billion. With the consensus EPS estimate being $0.58, the EPS surprise was -4.99%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare t ...

4Q 2025 Earnings Conference Call & Webcast February 25, 2026 www.talosenergy.com NYSE: TALO 1 Cautionary Statements Cautionary Statements The information in this presentation includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements, other than statements of historical fact included in this presentation, regarding our strategy ...

Acadia Healthcare Company (NasdaqGS:ACHC) Q4 2025 Earnings call February 25, 2026 09:00 AM ET Speaker10Please note this event is being recorded. I would now like to turn the conference over to Mr. Patrick Feeley, Senior Vice President, Head of Investor Relations. Please go ahead, sir.Speaker11Thank you. Good morning. This morning, we issued a press release announcing our fourth quarter 2025 financial results. This press release can be found in the Investor Relations section of the acadiahealthcare.com websi ...

Core Insights - Precipio, Inc. has reported strong preliminary financial results for Q4-2025 and fiscal year 2025, highlighting significant growth in revenue and positive cash flow metrics [1][5]. Financial Performance - Revenue Growth: Precipio's revenues increased from $18.5 million in 2024 to $24.0 million in 2025, representing a 30% year-over-year increase. Q4-2025 revenues were $6.7 million, up 23% from $5.4 million in Q4-2024 [5]. - Positive Adjusted EBITDA: The company will report Adjusted EBITDA of $0.95 million for Q4-2025 and $1.23 million for the full year 2025, compared to $0.40 million in Q4-2024 and a loss of $1.5 million for the full year 2024 [5]. - Positive Operating Cash Flow: Precipio will report $368,000 of positive operating cash flow during Q4-2025 and a total of $688,000 for 2025, compared to $439,000 generated from operations in 2024 [5]. Management Commentary - The CEO, Ilan Danieli, emphasized the importance of becoming an EBITDA and cash-flow positive business, allowing for investments in long-term growth projects rather than focusing solely on short-term cash burn [2]. The company experienced a strong performance in 2025, with shareholders seeing their value triple [2]. Company Overview - Precipio is a healthcare biotechnology company focused on cancer diagnostics, aiming to address cancer misdiagnoses through innovative diagnostic products and services that enhance accuracy and improve patient outcomes [6].

Shares of Vedanta Ltd soared over 5 per cent in early trade on Wednesday after Bank of America Corporation (BofA) upgraded the stock to buy from neutral and sharply raised its price target to ₹840 from ₹480, signalling strong upside potential from current levels.At 10.29 am, the stock traded at day’s high of ₹731.50, up 5.2 per cent from the previous close of ₹695.10.KEY HIGHLIGHTS Vedanta shares little over 5% BoFA updrages the stock to buy at a higher target price of ₹840 per share BoFA lifts EBITDA est ...

Income3,589,7172,804,945(21.9)Majority Net Income3,414,5812,713,713(20.5)Earnings per Share (in pesos)11.38199.0457(20.5)Earnings per ADS (in US$)6.32295.0251(20.5)Capex2,532,6983,899,34454.0Cash & Cash Equivalents20,083,45711,116,335(44.6)Net Debt(6,724,001)16,370,228(343.5)Net Debt/ LTM EBITDA(0.3)0.8(338.5)Operational HighlightsPassenger TrafficMexico10,105,37010,114,3320.1San Juan3,199,5453,100,354(3.1)Colombia4,433,3794,684,9685.71Unless otherwise stated, all financial figures are unaudited and prepare ...

Peter said the Mount Holly expansion is scheduled to begin in April, with Century planning to restart the last 25% of idled capacity and ramp it through the second quarter. He said the restart involves 50,000 tons of incremental volume, bringing Mount Holly to about 220,000 tons of annual production, with completion expected by the end of June.In the U.S., Peter said Century has 450,000 tons of capacity once Mount Holly is “up and running,” and noted the company is moving toward 1.4 million tons of nameplat ...

Sotera Health Company (NasdaqGS:SHC) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Company ParticipantsDavid Windley - Managing Director and Founding Member of Healthcare Equity Research TeamJason Peterson - VP of Investor Relations and TreasuryJonathan M. Lyons - CFOMichael Petras - Chairman and CEOSam Eiber - Equity Research AssociateConference Call ParticipantsBrett Fishman - VP and Senior Equity Research AnalystCasey Woodring - VP and Senior Equity Research AnalystChristine Rains - Healthcare Equi ...